Hyster Yale Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.5B-18.5% YoYTTM through 30 Jun 2026
Net Income -$116.9M-182.2% YoYTTM through 30 Jun 2026
Free Cash Flow $14.8MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 15.7% |
| EBITDA Margin | -1.0% |
| Operating Margin | -3.5% |
| Net Margin | -3.3% |
Returns
-23.1%ROE
-4.9%ROA
Balance Sheet Health
Debt / Equity1.12x
Current Ratio1.28x
Net Debt$424M
Cash & Equivalents$72.6M
Quality Metrics
Altman Z-Score2.24
Piotroski F-Score2 / 9
FCF Margin0.4%
Rule of 401.0
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $3.8B
Diluted EPS-$6.58TTMFY2025: $-3.40
Dividend
$0.73Per share, FY20263.90%Yield-10.8%5-yr growth
Capital Allocation
R&D Spend$137.2M
Capex Intensity1.8%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.